ER covalent antagonist-1
ER covalent antagonist-1 (Compound 39D) is the antagonist for estrogen receptor α (ERα) . ER covalent antagonist-1 inhibits the proliferation of ERα-positive cell MCF-7 with an IC50 of 0.98 μM, arrests the cell cycle at G0/G1 phase, and induces apoptosis. ER covalent antagonist-1 exhibits antitumor efficacy in mouse model[1].
Product Specifications
CAS Number
[2757498-74-9]
UNSPSC
12352005
Target
Apoptosis; Estrogen Receptor/ERR
Related Pathways
Apoptosis; Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
O=C(C1=CC=CC=C1)C(SC2=CC(O)=CC=C23)=C3OC4=CC=C(C=C4)OC5CN(C5)C/C=C/C(N6CCCCC6)=O
Molecular Formula
C33H32N2O5S
Molecular Weight
568.68
References & Citations
[1]Bai C, et al., X-ray crystallography study and optimization of novel benzothiophene analogs as potent selective estrogen receptor covalent antagonists (SERCAs) with improved potency and safety profiles. Bioorg Chem. 2023 Dec;141:106919.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
036336-FITC 200 µL
Gsta3, CT (Gsta3, Gstyc, Glutathione S-transferase A3, GST class-alpha member 3, Glutathione S-transferase Ya3, Glutathione S-transferase Yc) (FITC) discontinued
Ask
View Details